SK Bio-Pharmaceuticals

Pharmaceutical research and development is a long and rigorous process that consumes overwhelming amount of valuable resources. Therefore, every research and development project requires support from investors who can share the inherent financial risks. SKBP is continually seeking such investors who will also share synergetic benefits from our success.

SKBP has multiple pharmaceutical products under development, including drugs for depression, convulsions, psychoses, anxiety, and diabetes. Future R & D efforts will focus on drugs for inflammation, arthritis, and pain management.

Our research and development have resulted in two Investigational New Drug Applications in the United States and licensing of the late stage biopharmaceutical products to Johnson & Johnson.